VYNT

Vyant Bio, Inc. Common Stock
VYNT

Overview Fund Activity
Delisted

VYNT was delisted on the 12th of May, 2023.

Back to rankings

17 hedge funds and large institutions have $222K invested in Vyant Bio, Inc. Common Stock in 2022 Q4 according to their latest regulatory filings, with 3 funds opening new positions, 0 increasing their positions, 14 reducing their positions, and 12 closing their positions.

Holders
17
Holders Change
-9
Holders Change %
-34.62%
% of All Funds
0.27%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
3
Increased
–
Reduced
14
Closed
12
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

1
MC
1
Mayo Clinic
Minnesota
$19.4K
2
HF
2
HRT Financial
New York
$11K

Top Sellers

1
Vanguard Group
1
Vanguard Group
Pennsylvania
$102K
2
CAPTRUST Financial Advisors
2
CAPTRUST Financial Advisors
North Carolina
$0
3
Geode Capital Management
3
Geode Capital Management
Massachusetts
$27K
4
BlackRock
4
BlackRock
New York
$18.7K
5
State Street
5
State Street
Massachusetts
$10.6K
Name Market Value Shares Shares
Change 		Shares
Change %
Mariner
26
Mariner
Kansas
– – -10,273 Closed
Osaic Holdings
27
Osaic Holdings
Arizona
$0 24 -96 -80%
Barclays
28
Barclays
United Kingdom
$0 3 -12 -80%
CFGS
29
Concourse Financial Group Securities
Alabama
– – – –
Royal Bank of Canada
30
Royal Bank of Canada
Ontario, Canada
$0 3 +3 New
1
2